108 related articles for article (PubMed ID: 1948815)
1. Preparation of succinylthrombin and its effects in vivo on the coagulation system.
Nakagomi K; Yokota I; Ajisaka K
Thromb Res; 1991 Jul; 63(1):111-21. PubMed ID: 1948815
[TBL] [Abstract][Full Text] [Related]
2. Effects of acetylthrombin on protein C activation and fibrinogen clotting.
Nakagomi K; Ajisaka K; Yokota I
Thromb Res; 1990 Aug; 59(4):713-22. PubMed ID: 1964250
[TBL] [Abstract][Full Text] [Related]
3. Chemical modification of alpha-thrombin and in vitro characterization of its anticoagulant activity.
Nakagomi K; Ajisaka K
Biochem Int; 1990 Oct; 22(1):75-84. PubMed ID: 2177988
[TBL] [Abstract][Full Text] [Related]
4. Antithrombotic effects of thrombin-induced activation of endogenous protein C in primates.
Hanson SR; Griffin JH; Harker LA; Kelly AB; Esmon CT; Gruber A
J Clin Invest; 1993 Oct; 92(4):2003-12. PubMed ID: 8408654
[TBL] [Abstract][Full Text] [Related]
5. Activation of protein C in vivo.
Comp PC; Jacocks RM; Ferrell GL; Esmon CT
J Clin Invest; 1982 Jul; 70(1):127-34. PubMed ID: 6177716
[TBL] [Abstract][Full Text] [Related]
6. Influence of recombinant hirudin on tissue-factor-induced activation of coagulation in rabbits.
Kouz J; Czech J; Nicolay U; Dickneite G
Haemostasis; 1996; 26(4):179-86. PubMed ID: 8872128
[TBL] [Abstract][Full Text] [Related]
7. In vivo behavior of detergent-solubilized purified rabbit thrombomodulin on intravenous injection into rabbits.
Ehrlich HJ; Esmon NL; Bang NU
J Lab Clin Med; 1990 Feb; 115(2):182-9. PubMed ID: 2153745
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous and systemic effects of varying doses of brown recluse spider venom in a rabbit model.
McGlasson DL; Harroff HH; Sutton J; Dick E; Elston DM
Clin Lab Sci; 2007; 20(2):99-105. PubMed ID: 17557708
[TBL] [Abstract][Full Text] [Related]
9. Influence of red algal sulfated polysaccharides on blood coagulation and platelets activation in vitro.
Sokolova EV; Byankina AO; Kalitnik AA; Kim YH; Bogdanovich LN; Solov'eva TF; Yermak IM
J Biomed Mater Res A; 2014 May; 102(5):1431-8. PubMed ID: 23765560
[TBL] [Abstract][Full Text] [Related]
10. Effect of Toona microcarpa Harms leaf extract on the coagulation system.
Chen H; Jin M; Wang YF; Wang YQ; Meng L; Li R; Wang JP; Gao L; Kong Y; Wei JF
Biomed Res Int; 2014; 2014():615363. PubMed ID: 24818147
[TBL] [Abstract][Full Text] [Related]
11. Enhanced protein C activation and inhibition of fibrinogen cleavage by a thrombin modulator.
Berg DT; Wiley MR; Grinnell BW
Science; 1996 Sep; 273(5280):1389-91. PubMed ID: 8703074
[TBL] [Abstract][Full Text] [Related]
12. Structure/function analyses of recombinant variants of human factor Xa: factor Xa incorporation into prothrombinase on the thrombin-activated platelet surface is not mimicked by synthetic phospholipid vesicles.
Larson PJ; Camire RM; Wong D; Fasano NC; Monroe DM; Tracy PB; High KA
Biochemistry; 1998 Apr; 37(14):5029-38. PubMed ID: 9538022
[TBL] [Abstract][Full Text] [Related]
13. Continuous thrombin infusion leads to a bleeding phenotype in sheep.
Siller-Matula JM; Miller I; Gemeiner M; Plasenzotti R; Bayer G; Mesteri I; Fabry A; Petroczi K; Nöbauer K; Razzazi-Fazeli E; Planchon S; Renaut J; Quehenberger P; Selzer E; Jilma B
Thromb Res; 2012 Aug; 130(2):226-36. PubMed ID: 22289207
[TBL] [Abstract][Full Text] [Related]
14. Study of the clotting, esterase and platelet aggregating activities of thrombin, acetylated thrombin and reptilase.
Tangen O; Bygdeman S
Scand J Haematol; 1972; 9(4):333-8. PubMed ID: 5073562
[No Abstract] [Full Text] [Related]
15. Differences in the clinically effective molar concentrations of four direct thrombin inhibitors explain their variable prothrombin time prolongation.
Warkentin TE; Greinacher A; Craven S; Dewar L; Sheppard JA; Ofosu FA
Thromb Haemost; 2005 Nov; 94(5):958-64. PubMed ID: 16363236
[TBL] [Abstract][Full Text] [Related]
16. Isolation and characterization of an in vivo thrombin-induced anticoagulant activity.
Hyde E; Wetmore R; Gurewich V
Scand J Haematol; 1974; 13(2):121-8. PubMed ID: 4417990
[No Abstract] [Full Text] [Related]
17. In vitro study of the anticoagulant effects of edoxaban and its effect on thrombin generation in comparison to fondaparinux.
Samama MM; Mendell J; Guinet C; Le Flem L; Kunitada S
Thromb Res; 2012 Apr; 129(4):e77-82. PubMed ID: 21851967
[TBL] [Abstract][Full Text] [Related]
18. Low molecular weight heparins prevent thrombin-induced thrombo-embolism in mice despite low anti-thrombin activity. Evidence that the inhibition of feed-back activation of thrombin generation confers safety advantages over direct thrombin inhibition.
Momi S; Nasimi M; Colucci M; Nenci GG; Gresele P
Haematologica; 2001 Mar; 86(3):297-302. PubMed ID: 11255277
[TBL] [Abstract][Full Text] [Related]
19. Prophylactic fibrinogen infusion in cardiac surgery patients: effects on biomarkers of coagulation, fibrinolysis, and platelet function.
Karlsson M; Ternström L; Hyllner M; Baghaei F; Skrtic S; Jeppsson A
Clin Appl Thromb Hemost; 2011 Aug; 17(4):396-404. PubMed ID: 20530054
[TBL] [Abstract][Full Text] [Related]
20. Experimental study on anticoagulant and antiplatelet aggregation activity of a chemically sulfated marine polysaccharide YCP.
Han F; Yao W; Yang X; Liu X; Gao X
Int J Biol Macromol; 2005 Sep; 36(4):201-7. PubMed ID: 16102810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
